Hypermarcas (OTCMKTS:HYPMY) Stock Crosses Below Two Hundred Day Moving Average – Time to Sell?

Hypermarcas (OTCMKTS:HYPMY) passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $4.34 and traded as low as $4.05. Hypermarcas shares last traded at $4.19, with a volume of 4,570 shares traded.

Analysts Set New Price Targets

Several brokerages recently commented on HYPMY. Jefferies Financial Group upgraded shares of Hypermarcas to a “strong-buy” rating in a research report on Monday, July 20th. Zacks Research raised shares of Hypermarcas to a “hold” rating in a research report on Wednesday, April 29th. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Buy”.

Hypermarcas Stock Performance

The firm has a 50 day moving average price of $4.09 and a 200-day moving average price of $4.34. The company has a market cap of $2.95 billion, a P/E ratio of 8.38 and a beta of 0.70.

Hypermarcas (OTCMKTS:HYPMY) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.14 earnings per share for the quarter, topping analysts’ consensus estimates of $0.13 by $0.01. Hypermarcas had a net margin of 19.77% and a return on equity of 14.63%. On average, sell-side analysts forecast that Hypermarcas will post 0.53 EPS for the current fiscal year.

Hypermarcas Company Profile

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.